Breaking News
Get 40% Off 0
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now
Close

Traws Pharma Inc (TRAW)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Traws Pharma's earnings

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.641 +0.007    +1.10%
29/04 - Closed. Currency in USD ( Disclaimer )
Pre Market
0.623
-0.018
-2.871%
13:16:42 - Real-time Data
  • Volume: 24,156
  • Bid/Ask: 0.623 / 0.655
  • Day's Range: 0.614 - 0.659
Type:  Equity
Market:  United States
Traws Pharma 0.641 +0.007 +1.10%

Traws Pharma Company Profile

 
Read the Traws Pharma Inc company profile to learn more about the business and the management team. View Traws Pharma Inc facts about employee data, company products and services, and contact information.
IndustryPharmaceuticals
SectorHealthcare
Employees

18

Equity Type

ORD

Traws Pharma, Inc., a clinical stage biopharmaceutical company, focuses on developing small molecule oral product candidates for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and COVID19 that are designed to address treatment resistance, such as TRX01 (travatrelvir), a Mpro/3CL inhibitor in development for the treatment of COVID19; and TRX100 (viroxavir), an endonuclease inhibitor in development for the treatment of pandemic influenza. It is also developing narazaciclib, a multi-kinase CDK4/6 inhibitor, which is in Phase 1/2 clinical trials in patients with cancer, with or without co-administration of letrozole to define the recommended phase 2 dose for further development in endometrial cancer; and oral rigosertib, which is administered alone or in combination for investigation in various cancers. The company was formerly known as Onconova Therapeutics, Inc. and changed its name to Traws Pharma, Inc. in April 2024. Traws Pharma, Inc. was incorporated in 1998 and is headquartered in Newtown, Pennsylvania.

Contact Information

Address 12 Penns Trail
Newtown, 18940
United States
Phone 267 759 3680
Fax 267 759 3681

Top Executives

Name Age Since Title
Alan R. Williamson 87 2016 Chairman of Scientific Advisory Board
Jack E. Stover 71 2016 Independent Director
Werner Cautreels 72 2024 CEO & Director
Nikolay Savchuk - 2024 COO & Director
Iain D. Dukes 66 2024 Executive Chairman
Mary Theresa Shoemaker 62 2020 Independent Director
George F. Vande Woude - - Member of Scientific Advisory Board
Stephen D. Nimer 69 2005 Member of Scientific Advisory Board
David Ross Parkinson 74 - Member of Scientific Advisory Board
Anna Marie Skalka - - Member of Scientific Advisory Board
James J. Marino 74 2015 Independent Director
Ross C. Donehower - - Member of Scientific Advisory Board
Trafford Clarke 65 2022 Independent Director
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

TRAW Price Commentary

Write your thoughts about Traws Pharma Inc
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Akila Chamika
Akila Chamika May 24, 2021 11:55
Saved. See Saved Items.
This comment has already been saved in your Saved Items
prediction from analysis is 17$ on 1st week of june. no sell ratings upto now
Kelvin Yeo
Kelvin Yeo May 24, 2021 10:22
Saved. See Saved Items.
This comment has already been saved in your Saved Items
cheating investor$$$
Neteli Neteli
Neteli Neteli May 21, 2021 10:20
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Reverse Split - 1 for 15
Akila Chamika
Akila Chamika May 20, 2021 20:21
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what will be the end of today
Ralf Weber
Ralf Weber Mar 16, 2021 16:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Apparently RS is coming
Adriano Lucas
Adriano Lucas Mar 01, 2021 14:14
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Good news coming this month check out hold strong you will be rewarded 🤑
Michael Price
Michael Price Feb 18, 2021 1:32
Saved. See Saved Items.
This comment has already been saved in your Saved Items
next 6hourz? up or down? thoughts
Michael Price
Michael Price Feb 17, 2021 20:19
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Buy or sell this? what's the thoughts?
Neteli Neteli
Neteli Neteli Feb 17, 2021 15:03
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Will this be the next Ocugen, Inc (OCGN)? I surely hope so...
Neteli Neteli
Neteli Neteli Feb 17, 2021 14:47
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Onconova Therapeutics, Inc. (NASDAQ:ONTX) SVP Abraham N. Oler bought 12,000 shares of the stock in a transaction that occurred on Tuesday, February 16th. --> something good is cooking?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email